Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s share price reached a new 52-week low during trading on Wednesday . The company traded as low as $5.80 and last traded at $5.9966, with a volume of 6505 shares. The stock had previously closed at $5.89.
Analyst Upgrades and Downgrades
Separately, Zacks Research raised Oxford BioMedica to a “hold” rating in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock has an average rating of “Hold”.
Get Our Latest Report on OXBDF
Oxford BioMedica Trading Up 1.8%
Oxford BioMedica Company Profile
Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.
Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.
Further Reading
- Five stocks we like better than Oxford BioMedica
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
